DE602005010693D1 - Piperazinderivate von alkyloxindolen - Google Patents

Piperazinderivate von alkyloxindolen

Info

Publication number
DE602005010693D1
DE602005010693D1 DE602005010693T DE602005010693T DE602005010693D1 DE 602005010693 D1 DE602005010693 D1 DE 602005010693D1 DE 602005010693 T DE602005010693 T DE 602005010693T DE 602005010693 T DE602005010693 T DE 602005010693T DE 602005010693 D1 DE602005010693 D1 DE 602005010693D1
Authority
DE
Germany
Prior art keywords
alkyloxindolses
piperazine derivatives
derivatives
cadiovascular
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005010693T
Other languages
English (en)
Inventor
Balazs Volk
Jozsef Barkoczy
Gyula Simig
Tibor Mezei
Dezsofi Rita Kapillerne
Istvan Gacsalyi
Katalin Pallagi
Gabor Gigler
Gyoergy Levay
Krisztina Moricz
Csilla Leveleki
Nora Sziray
Gabor Szenasi
Andras Egyed
Laszlo Gabor Harsing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Pharmaceuticals PLC filed Critical Egis Pharmaceuticals PLC
Publication of DE602005010693D1 publication Critical patent/DE602005010693D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
DE602005010693T 2004-05-11 2005-05-11 Piperazinderivate von alkyloxindolen Active DE602005010693D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0400953A HUP0400953A3 (en) 2004-05-11 2004-05-11 Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
PCT/HU2005/000050 WO2005108364A1 (en) 2004-05-11 2005-05-11 Piperazine derivatives of alkyl oxindoles

Publications (1)

Publication Number Publication Date
DE602005010693D1 true DE602005010693D1 (de) 2008-12-11

Family

ID=89982207

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005010693T Active DE602005010693D1 (de) 2004-05-11 2005-05-11 Piperazinderivate von alkyloxindolen

Country Status (27)

Country Link
US (1) US7910591B2 (de)
EP (1) EP1751105B1 (de)
JP (1) JP2007537227A (de)
CN (1) CN101010296B (de)
AT (1) ATE412633T1 (de)
AU (1) AU2005240843B2 (de)
BG (1) BG109769A (de)
CA (1) CA2566096A1 (de)
CZ (1) CZ2006779A3 (de)
DE (1) DE602005010693D1 (de)
DK (1) DK1751105T3 (de)
EA (1) EA010789B1 (de)
ES (1) ES2319795T3 (de)
HR (1) HRP20060420A2 (de)
HU (1) HUP0400953A3 (de)
IL (1) IL179028A (de)
MX (1) MXPA06013068A (de)
NO (1) NO20065609L (de)
NZ (1) NZ551545A (de)
PL (2) PL381615A1 (de)
PT (1) PT1751105E (de)
RS (1) RS20060621A (de)
SI (1) SI1751105T1 (de)
SK (1) SK51102006A3 (de)
UA (1) UA84927C2 (de)
WO (1) WO2005108364A1 (de)
ZA (1) ZA200610345B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
CN104163813B (zh) * 2013-05-16 2017-02-01 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
MX173362B (es) * 1987-03-02 1994-02-23 Pfizer Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB8830312D0 (en) * 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
WO1998008816A1 (fr) * 1996-08-26 1998-03-05 Meiji Seika Kaisha, Ltd. Derives d'indoxyle et psychotropes
HUP0400953A3 (en) * 2004-05-11 2008-02-28 Egis Gyogyszergyar Nyilvanosan Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use

Also Published As

Publication number Publication date
EP1751105A1 (de) 2007-02-14
BG109769A (bg) 2008-03-31
SK51102006A3 (sk) 2007-05-03
MXPA06013068A (es) 2007-05-04
PL381615A1 (pl) 2007-06-11
CZ2006779A3 (cs) 2007-03-07
NZ551545A (en) 2010-07-30
PL1751105T3 (pl) 2009-07-31
EA010789B1 (ru) 2008-10-30
EP1751105B1 (de) 2008-10-29
IL179028A0 (en) 2007-03-08
PT1751105E (pt) 2009-02-10
IL179028A (en) 2011-08-31
JP2007537227A (ja) 2007-12-20
CN101010296A (zh) 2007-08-01
ZA200610345B (en) 2008-05-28
NO20065609L (no) 2007-02-05
US7910591B2 (en) 2011-03-22
HRP20060420A2 (en) 2007-04-30
AU2005240843B2 (en) 2012-02-02
US20080161323A1 (en) 2008-07-03
RS20060621A (en) 2008-09-29
CA2566096A1 (en) 2005-11-17
DK1751105T3 (da) 2009-03-09
WO2005108364A1 (en) 2005-11-17
ES2319795T3 (es) 2009-05-12
UA84927C2 (en) 2008-12-10
EA200602084A1 (ru) 2007-04-27
CN101010296B (zh) 2011-08-17
ATE412633T1 (de) 2008-11-15
AU2005240843A1 (en) 2005-11-17
HU0400953D0 (en) 2004-07-28
HUP0400953A2 (en) 2007-09-28
SI1751105T1 (sl) 2009-06-30
HUP0400953A3 (en) 2008-02-28

Similar Documents

Publication Publication Date Title
CY1116754T1 (el) Παραγωγα νιτροκατεχολης ως αναστολεις της comt
DE602005009318D1 (de) Kondensierte heteroyralderivate zur verwendung als p38-kinase-inhibitoren
NO20071240L (no) Terapeutiske anvendelser av RTP801 inhibitorer
DE60314603D1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
BRPI0517015A (pt) compostos e composições como inibidores de atividade de receptor 1 de canabinóide
ATE438404T1 (de) Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
DE602006004844D1 (de) Pyrrolopyrimidine verwendbar als protein kinase inhibitoren
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
GEP20084550B (en) Substituted morpholine compounds for the treatment of central nervous system disorders
CY1111733T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
ATE553093T1 (de) Indazolderivate zur hemmung von trpv1 und verwendungen davon
ATE413392T1 (de) Kondensierte heteroyralderivate und deren verwendung als p38-kinase-inhibitoren
DE602006017574D1 (de) Als protein-kinase-inhibitoren nutzbare benzimidazole
NI200700032A (es) Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas
CY1107204T1 (el) Πιπεραζινοβενζοθειαζολια ως ουσιες για την θεραπευτικη αντιμετωπιση εγκεφαλικων ισχαιμικων διαταραχων ή διαταραχων του κνς
ATE412633T1 (de) Piperazinderivate von alkyloxindolen
ATE532514T1 (de) Piperidin- und piperazinderivate
NO20071466L (no) 3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE
EA200602081A1 (ru) Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7
ATE534638T1 (de) Piperazin-derivate
ATE423772T1 (de) Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin
ATE412634T1 (de) Piperazinderivate von alkyloxindolen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition